Raymond James & Associates Lumira Dx LTD Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$0.06 - $0.27 $6,652 - $29,938	110,883 Added 600.08%	129,361 $7,000
Q3 2023 Oct 24, 2023	SELL	$0.24 - $0.48 $1,320 - $2,640	-5,500 Reduced 22.94%	18,478 $4,000
Q2 2023 Jul 25, 2023	SELL	$0.35 - $0.82 $3,102 - $7,267	-8,863 Reduced 26.99%	23,978 $11,000
Q1 2023 Apr 14, 2023	BUY	$0.46 - $1.2 $959 - $2,503	2,086 Added 6.78%	32,841 $15,000
Q4 2022 Feb 08, 2023	SELL	$0.85 - $1.49 $198,953 - $348,753	-234,063 Reduced 88.39%	30,755 $27,000
Q3 2022 Oct 25, 2022	BUY	$0.15 - $3.05 $39,722 - $807,694	264,818 New	264,818 $270,000

365K

Ticker LMDX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 170,688,000
Market Cap $1.71M
Description
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The compa...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.